These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34136373)

  • 1. Updates on the Treatment of Erythrodermic Psoriasis.
    Lo Y; Tsai TF
    Psoriasis (Auckl); 2021; 11():59-73. PubMed ID: 34136373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics for the Management of Erythrodermic Psoriasis: An Updated Review.
    Potestio L; Camela E; Cacciapuoti S; Fornaro L; Ruggiero A; Martora F; Battista T; Megna M
    Clin Cosmet Investig Dermatol; 2023; 16():2045-2059. PubMed ID: 37560255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological treatment for erythrodermic psoriasis.
    Dogra S; Mehta H
    Expert Opin Biol Ther; 2022 Dec; 22(12):1531-1543. PubMed ID: 36154361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.
    Shao S; Wang G; Maverakis E; Gudjonsson JE
    Drugs; 2020 Apr; 80(6):525-534. PubMed ID: 32180204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab.
    Megna M; Ruggiero A; Salsano A; Lauletta G; Portarapillo A; Torta G; Martora F; Potestio L
    Clin Cosmet Investig Dermatol; 2023; 16():3503-3507. PubMed ID: 38077922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of erythrodermic psoriasis successfully treated with guselkumab.
    Megna M; Ruggiero A; Camela E; Fabbrocini G; Marasca C
    Dermatol Ther; 2020 Mar; 33(2):e13238. PubMed ID: 31997488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab.
    Chiang CY; Tsai TF
    Dermatol Ther (Heidelb); 2021 Feb; 11(1):301-306. PubMed ID: 33400156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of erythrodermic psoriasis successfully treated with ixekizumab.
    Megna M; Gallo L; Balato N; Balato A
    Dermatol Ther; 2019 Mar; 32(2):e12825. PubMed ID: 30650216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of treatment strategies for erythrodermic psoriasis.
    Reynolds KA; Pithadia DJ; Lee EB; Liao W; Wu JJ
    J Dermatolog Treat; 2021 Feb; 32(1):49-55. PubMed ID: 31682547
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of erythrodermic psoriasis with biologics: A systematic review.
    Carrasquillo OY; Pabón-Cartagena G; Falto-Aizpurua LA; Santiago-Vázquez M; Cancel-Artau KJ; Arias-Berrios G; Martín-García RF
    J Am Acad Dermatol; 2020 Jul; 83(1):151-158. PubMed ID: 32247872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrodermic Psoriasis Successfully Treated with Anti IL-17: A Case Series.
    Bernardini N; Skroza N; Proietti I; Mambrin A; Marchesiello A; Tolino E; Balduzzi V; Potenza C
    Acta Dermatovenerol Croat; 2021 Nov; 29(4):191-195. PubMed ID: 36896689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrodermic Psoriasis Managed with Risankizumab.
    Alajlan A; Madani A; Qadoumi TA; Aljaloud A; Alessa M
    Case Rep Dermatol; 2022; 14(2):219-224. PubMed ID: 36158862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrodermic psoriasis: pathophysiology and current treatment perspectives.
    Singh RK; Lee KM; Ucmak D; Brodsky M; Atanelov Z; Farahnik B; Abrouk M; Nakamura M; Zhu TH; Liao W
    Psoriasis (Auckl); 2016; 6():93-104. PubMed ID: 28856115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrodermic Psoriasis Treated with Golimumab: A Case Report.
    Lee WK; Kim GW; Cho HH; Kim WJ; Mun JH; Song M; Kim HS; Ko HC; Kim MB; Kim BS
    Ann Dermatol; 2015 Aug; 27(4):446-9. PubMed ID: 26273164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of Erythrodermic psoriasis treated with Golimumab.
    Kudsi M; Alzabibi MA; Shibani M
    Ann Med Surg (Lond); 2022 Jun; 78():103961. PubMed ID: 35734731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrodermic psoriasis successfully and rapidly treated with brodalumab: Report of two cases.
    Megna M; Fabbrocini G; Ferrillo M; Cinelli E
    Dermatol Ther; 2020 Nov; 33(6):e14351. PubMed ID: 32981222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of refractory erythrodermic psoriasis effectively treated with secukinumab and a review of the literature.
    Liu LC; Jin XH; Sun C; Xia JX
    Dermatol Ther; 2021 Mar; 34(2):e14825. PubMed ID: 33527631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study.
    Yamanaka K; Okubo Y; Yasuda I; Saito N; Messina I; Morita A
    J Dermatol; 2023 Feb; 50(2):195-202. PubMed ID: 36514850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ixekizumab as treatment of erythrodermic psoriasis.
    Trovato E; Orsini C; Russo F; Cortonesi G; Rubegni P
    Dermatol Ther; 2021 Mar; 34(2):e14868. PubMed ID: 33571383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report.
    Lu X; Wang W
    Clin Cosmet Investig Dermatol; 2023; 16():1977-1981. PubMed ID: 37539023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.